Hvis denne uønskede hyperstimulation indtræder (dvs. ikke som en del af kontrolleret ovariehyperstimulation ved medicinsk assisteret reproduktion), bør administrationen af Puregon afbrydes.
If this unwanted ovarian hyperstimulation occurs (i. e. not as part of controlled ovarian hyperstimulation in medically assisted reproduction programs), the administration of Puregon should be discontinued.